(18)F-FDG PET/CT helps differentiate peripheral nerve myeloid sarcoma from a presumed benign nerve sheath tumor Miscellaneous


Authors: Das, J. P.; Riedl, C. C.; Ulaner, G. A.
Title: (18)F-FDG PET/CT helps differentiate peripheral nerve myeloid sarcoma from a presumed benign nerve sheath tumor
Abstract: A 21-year-old man with NF1 (neurofibromatosis type 1) mutation and in remission from acute myeloid leukemia presented with a painless mass in the left upper limb. MRI showed a soft-tissue mass involving the ulnar nerve presumed to be a nerve sheath tumor. 18F-FDG PET/CT was performed demonstrating high FDG avidity in the mass, prompting a biopsy. Histopathology and immunohistochemistry of the biopsy sample demonstrated myeloid sarcoma of the ulnar nerve. This case highlights the role of 18F-FDG PET/CT in raising the suspicion of malignancy in otherwise presumably benign lesions of the nerve. © 2020 Wolters Kluwer Health, Inc.
Keywords: fdg; pet/ct; granulocytic sarcoma; myeloid sarcoma; extramedullary leukemia
Journal Title: Clinical Nuclear Medicine
Volume: 45
Issue: 12
ISSN: 0363-9762
Publisher: Lippincott Williams & Wilkins  
Date Published: 2020-12-01
Start Page: 989
End Page: 991
Language: English
DOI: 10.1097/rlu.0000000000003299
PUBMED: 32956122
PROVIDER: scopus
DOI/URL:
Notes: Image -- Export Date: 1 December 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christopher Riedl
    60 Riedl
  2. Gary Ulaner
    147 Ulaner
  3. Jeeban Paul Das
    43 Das